Welcome to our dedicated page for Ridgetech SEC filings (Ticker: RDGT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ridgetech, Inc. (NASDAQ: RDGT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a Cayman Islands exempted company and foreign private issuer. Ridgetech files reports with the U.S. Securities and Exchange Commission under the Securities Exchange Act of 1934, including Form 20-F annual reports and Form 6-K current reports that describe its wholesale distribution of pharmaceutical and other healthcare products in China.
Through these filings, investors can review how Ridgetech presents its business model and segment information, including its focus on online and offline wholesale distribution and the classification of its historical retail pharmacy operations as discontinued operations under ASC 205. Financial statements contained in these reports provide details on revenues, cost of goods sold, gross profit, operating expenses, income or loss from continuing and discontinued operations, and cash flows from operating, investing and financing activities.
Ridgetech’s 6-K filings also document capital markets transactions and corporate governance matters. Examples include private placements of ordinary shares and warrants with non-U.S. accredited investors, shareholder rights agreements that grant demand and piggyback registration rights, and explanations of how the company relies on Cayman Islands corporate governance practices where permitted by Nasdaq rules. Other filings report the results of annual general meetings, including director elections, auditor ratification, approval of share consolidations and adoption of amended and restated memorandum and articles of association, as well as updates to equity incentive plans.
On Stock Titan, users can see new Ridgetech filings as they are made available from EDGAR and use AI-powered summaries to interpret complex documents. These tools help clarify the implications of Form 20-F disclosures, Form 6-K current reports, registration statements on Forms F-3 and S-8, and other exhibits related to Ridgetech’s financing arrangements and governance structure, making it easier to understand the company’s regulatory and financial reporting history.
Ridgetech Inc. (RDGT) reports the completion of a capital reduction and share subdivision effective September 2, 2026. The par value of each issued and outstanding ordinary share was reduced from US$0.15 to US$0.0001 by cancelling the paid-up capital difference. Immediately afterward, each authorized but unissued ordinary share was subdivided into 1,500 new ordinary shares of par value US$0.0001 each. Following these changes, authorized share capital is US$36,010,000, divided into 360,000,000,000 ordinary shares at US$0.0001 par value and 10,000,000 preferred shares at US$0.001 par value, including 100,000 Series A Preferred Shares that are issued and designated.
Ridgetech Inc. (RDGT) reports that shareholders approved a special resolution at the August 25, 2026 annual general meeting to adopt a Sixth Amended and Restated Memorandum and Articles of Association, fully replacing the prior version. The new governing documents reflect the creation of Series A Preferred Shares and their associated rights, and revise the quorum requirement for general meetings so that a quorum now consists of one or more members holding shares representing at least 33-1/3% of the voting power of issued and outstanding voting shares entitled to vote, present in person, by proxy, or by authorized representative. The updated Memorandum and Articles were filed with the General Registry of the Cayman Islands on August 27, 2026.
Ridgetech Inc. (RDGT) reported the results of its August 25, 2026 annual general meeting. Holders of 1,397,501 ordinary shares and 100,000 Series A Preferred Shares were represented, satisfying the quorum requirement under its Fifth Amended and Restated Memorandum and Articles of Association.
As of the July 17, 2026 record date, 3,629,540 ordinary shares and 100,000 Series A Preferred Shares were issued and outstanding. Each ordinary share carried one vote and each Series A Preferred Share carried 100 votes, voting together as a single class. All four director nominees, Lingtao Kong, Caroline Wang, Jiangliang He and Genghua Gu, received approximately 11.39 million votes in favor with about 2,700 votes withheld each.
Shareholders also approved the ratification of the independent accountants, amendments to adopt a Sixth and then Further Amended and Restated Memorandum and Articles of Association, a capital reduction, an ordinary share consolidation, and an equity incentive plan, with each proposal receiving roughly 11.39 million votes in favor.
Ridgetech, Inc. is convening an annual general meeting on August 25, 2026 to elect four directors, ratify its auditor, and seek shareholder approval for significant changes to its share capital structure and equity incentive plan.
Holders of record on July 17, 2026 may cast an aggregate of 13,629,540 votes, including 3,629,540 ordinary shares and 100,000 Series A Preferred Shares, each Series A carrying 100 votes and issued to Board chair Lingtao Kong. Key proposals include adopting a Sixth Amended and Restated Memorandum and Articles of Association to embed Series A rights and revise the quorum to one-third of voting power, a Capital Reduction cutting ordinary share par value from US$0.15 to US$0.0001 and increasing authorized ordinary shares to 360,000,000,000, and Board authority for a potential ordinary share consolidation at ratios from 1:20 to 1:200 to help satisfy Nasdaq listing rules. Additional proposals would restate the charter to reflect any approved capital changes and adopt a Fifth Amended and Restated 2010 Equity Incentive Plan reserving 1,504,155 ordinary shares and extending its termination date to January 14, 2030. Annex A contains the Sixth Amended and Restated charter, described as adopted and effective on August 25, 2026.
Ridgetech, Inc., a Cayman Islands holding company listed on Nasdaq as RDGT, reports on a business now focused on wholesale and online distribution of pharmaceutical and healthcare products in China through PRC subsidiaries. In February 2025 it acquired Ridgeline and its Allright online platform business and divested Jiuxin Investment and its VIE-based retail pharmacy network, so it no longer uses VIEs. As of March 31, 2026 it had 133,090,838 ordinary shares outstanding; share data reflect a 1-for-150 reverse split effective April 7, 2026.
The company is highly dependent on sales to Jiuzhou Pharmacy under a three‑year supply agreement and on third‑party e‑commerce platforms for Allright, with one customer contributing 53.7% of 2026 sales and divested retail entities owing $13.6 million of payables at March 31, 2025. For the year ended March 31, 2026, total revenue increased by $12.19 million, or 10.2%, including offline wholesale revenue of $117.87 million and online platform revenue of $14.29 million. Extensive risk disclosures emphasize evolving PRC regulation of data, cybersecurity and overseas listings, foreign-exchange and cash‑transfer limits, HFCAA-related delisting risk despite a U.S.-inspected auditor, and material weaknesses in internal control over financial reporting.
Ridgetech, Inc. reported fiscal year 2026 revenue of $132.16 million for the year ended March 31, 2026, up 10.2% from $119.97 million in 2025 as it completed a shift to a wholesale-focused pharmaceutical and healthcare distribution model in China. Offline wholesale revenue was $117.87 million, slightly below $118.86 million a year earlier after the company curtailed some credit sales, while online platform revenue surged to $14.29 million from $1.11 million following the full-year contribution of the acquired Allright business.
Total gross profit rose to $4.75 million, lifting gross margin to 3.6% from 3.2%, but higher selling expenses of $3.04 million and general and administrative expenses of $3.58 million produced a loss from operations of $1.87 million. Net loss from continuing operations was $1.25 million versus $1.45 million in 2025, and overall net loss was $1.25 million, or $(17.21) per basic and diluted share, compared with net income of $10.20 million, or $275.87 per share, in 2025, when results included a large divestiture gain from discontinued operations.
Cash and cash equivalents were $17.91 million as of March 31, 2026, up from $12.78 million a year earlier, while net cash used in operating activities was $1.39 million.
Ridgetech, Inc., a Cayman Islands holding company with operations conducted through PRC subsidiaries, is establishing a new at-the-market equity program under a Form F-3 shelf. The company may sell up to $184,720,213 of ordinary shares from time to time through Pacific Century Securities, LLC as sales agent, which will receive a 3.5% commission and be deemed an underwriter.
Ordinary shares trade on the Nasdaq Capital Market under the symbol RDGT; the closing price was $1.23 on July 27, 2026. There were 3,629,540 ordinary shares outstanding before this offering and, assuming sales at $1.23, up to 153,808,575 shares could be outstanding afterward. Estimated net proceeds of up to $177,755,006 are intended for working capital and general corporate purposes. The disclosure emphasizes substantial legal, regulatory, cash-transfer, and HFCAA-related risks arising from having substantially all operations in China and from reliance on PRC subsidiaries for funds and potential dividends.
Ridgetech, Inc. entered into a new Sales Agreement with Pacific Century Securities, LLC to continue its at-the-market equity program, under which it may offer and sell ordinary shares, par value $0.15, having an aggregate offering price of up to $184,720,213.
Sales are made through Pacific Century as sales agent under the company’s effective Form F-3 shelf. Ridgetech is not obligated to sell any shares, and the agent is not required to buy shares on a principal basis. The company will pay a 3.5% commission on gross proceeds and reimburse up to $100,000 of specified expenses. This arrangement replaces a prior at-the-market program that was suspended in July 2026.
Ridgetech, Inc., a Cayman Islands company listed on Nasdaq, has elected to follow Cayman home country corporate governance practices in lieu of certain Nasdaq Listing Rules 5600 Series, supported by a legal opinion from its Cayman counsel confirming this election is permitted under Cayman law and its memorandum and articles of association.
The board authorized and designated 2,000,000 Series A Preferred Shares, each carrying 100 votes per share and convertible at the holder’s option into one ordinary share, subject to specified adjustments and automatic conversion on certain events. On July 16, 2026, chair Lingtao Kong agreed to subscribe for 100,000 Series A Preferred Shares at US$0.001 per share, for an aggregate subscription amount of US$100, after review and approval by the Audit Committee as a related party transaction. The issuance is intended to promote continuity of leadership and strategic direction, retain and incentivize the chair, and enhance the company’s ability to respond to hostile takeover or other unsolicited change-of-control transactions, while aiming to minimize economic dilution to existing shareholders.
Lingtao Kong filed Amendment No. 2 reporting his beneficial ownership of Ridgetech Inc. ordinary shares. He beneficially owns 114,834 Ordinary Shares, representing 3.2% of the outstanding ordinary shares, and holds sole voting and sole dispositive power over this entire amount.
The position consists of 14,834 Ordinary Shares and 100,000 Series A Preferred Shares, each Series A Preferred Share being convertible into one Ordinary Share under its Statement of Rights. The percentage interest is calculated using 3,629,540 Ordinary Shares outstanding as of July 16, 2026. Following a 1-for-150 reverse share split effective April 7, 2026, Kong held 14,834 Ordinary Shares, and on July 15, 2026 he acquired the 100,000 Series A Preferred Shares.